US BROKER MOVES: AMD upgraded at Raymond James; KLAR downgraded at Wolfe
UPGRADES
- AMD (AMD) Upgraded from Outperform to Strong Buy at Raymond James; PT USD 641
- Bread Financial (BFH) Upgraded from Peer Perform to Outperform at Wolfe Research; PT USD 130
- Capricor Therapeutics (CAPR) Upgraded from Perform to Outperform at Oppenheimer
- Dynatrace (DT) Upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 65
- Fluence Energy (FLNC) Upgraded from Sell to Neutral at UBS; PT USD 12
- Shift4 Payments (FOUR) Upgraded from Equal Weight to Overweight at Wells Fargo; PT USD 59
- Moderna (MRNA) Upgraded from Underperform to Peer Perform at Wolfe Research
- Summit Therapeutics (SMMT) Upgraded from Underperform to Market Perform at Bernstein SocGen Group; PT USD 11.90
DOWNGRADES
- Daqo New Energy (DQ) Downgraded from Neutral to Sell at Goldman Sachs; PT USD 10
- Fidelity National Information Services (FIS) Downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 46
- Five Below (FIVE) Downgraded from Buy to Hold at Loop Capital
- KLAR (KLAR) Downgraded from Outperform to Peer Perform at Wolfe Research
- Nutrien (NTR) Downgraded from Outperform to Sector Perform at National Bank Financial; PT USD 77
- Paymentus (PAY) Downgraded from Outperform to Peer Perform at Wolfe Research
- RLI (RLI) Downgraded from Hold to Underperform at Jefferies; PT USD 53
- VTEX (VTEX) Downgraded from Outperform to Market Perform at Itau BBA
INITIATIONS
- AgomAb Therapeutics (AGMB) Initiated at Overweight at Piper Sandler; PT USD 60
- Apnimed (APMD) Initiated at Buy at BofA Securities; PT USD 41
- Apnimed (APMD) Initiated at Outperform at Evercore ISI
- Apnimed (APMD) Initiated at Outperform at LifeSci Capital; PT USD 50
- Apnimed (APMD) Initiated at Overweight at Cantor Fitzgerald; PT USD 60
- Curbline Properties (CURB) Initiated at Buy at Jefferies; PT USD 36
- Factorial Energy (FAC) Initiated at Outperform at Oppenheimer; PT USD 8
- JBT Marel (JBTM) Initiated at Overweight at KeyBanc; PT USD 150
- Jersey Mike's Subs (JMKE) Initiated at Neutral at Goldman Sachs; PT USD 26
- Kodiak AI (KDK) Initiated at Outperform at Oppenheimer; PT USD 9
- Methode Electronics (MEI) Initiated at Buy at Craig; PT USD 30
- Midera Food Processing (MFP) Initiated at Sector Weight at KeyBanc
- Marvell Technology (MRVL) Initiated at Buy at Rosenblatt; PT USD 300
A broad daily ratings roundup, with two names carrying the weight: AMD's move to Strong Buy at Raymond James and the cluster of fresh coverage on Marvell, both of which sit squarely in the AI hardware trade that has driven single-name research flow. Individual upgrades and downgrades of this kind tend to move mid and small caps more than large caps, since in index-heavy names the rating itself rarely adds information beyond what positioning already reflects; the exception is where a call changes the ratings consensus mix enough to matter for quant screens. The Apnimed initiation cluster, with several houses launching on the same session, is the standard pattern around a recent listing or data event and typically marks the point where a new name enters the coverage universe and its float starts to be rated rather than just traded. Wolfe's paired moves, downgrading KLAR and Paymentus while upgrading Bread Financial and Moderna, read as relative-value reshuffling within sector coverage rather than a macro signal. The follow-ons that matter are any thesis notes accompanying the AMD and Marvell calls, since price target gaps of that size usually rest on specific revenue or share assumptions that peers then either validate or push back on. Aggregate flow of this kind is directionally informative at the sector level only when the upgrades and downgrades cluster, which here they do in semis and payments.